Nonalcoholic fatty liver disease: Targeted therapy in children - What is the right way?

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 8, 2011, Pages 425-426

  Alisi, Anna ^a   Nobili, Valerio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; METFORMIN; PLACEBO;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; HUMAN; INTERMETHOD COMPARISON; LIFESTYLE MODIFICATION; MOLECULARLY TARGETED THERAPY; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ALANINE TRANSAMINASE; CHILD; FATTY LIVER; HUMANS; LIFE STYLE; METFORMIN; TREATMENT OUTCOME; VITAMIN E;

EID: 80051544561     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2011.117     Document Type: Review

References (10)

1. Brunt, E. M. Pathology of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 7, 195-203 (2010).
2. Nobili, V. et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 48, 19-28 (2008).
3. Nobili, V. et al. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin. Ther. 30, 1168-1176 (2008). (Pubitemid 351978124)
4. Lavine, J. E. et al. Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. Contemp. Clin. Trials 31, 62-70 (2010).
5. Lavine, J. E. et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 305, 1659-1668 (2011).
6. Nobili, V. et al. Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial. Arch. Dis. Child. 96, 350-353 (2011).
7. Feldstein, A. E. et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 58, 1538-1544 (2009).
8. Alisi, A., Cianfarani, S., Manco, M., Agostoni, C. & Nobili, V. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment. Ann. Med. doi:10.3109/07853890.2010.547869.
9. Alisi, A., Locatelli, M. & Nobili, V. Nonalcoholic fatty liver disease in children. Curr. Opin. Clin. Nutr. Metab. Care 13, 397-402 (2010).
10. Iacono, A., Raso, G. M., Canani, R. B., Calignano, A. & Meli, R. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J. Nutr. Biochem. doi:10.1016/j.jnutbio. 2010.10.002.